Tramadol News and Research

RSS
Radiocarbon method proves Cameroon’s environment is contaminated with synthetic opioid

Radiocarbon method proves Cameroon’s environment is contaminated with synthetic opioid

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

AHS provides updated assessment of treatments for acute migraine

AHS provides updated assessment of treatments for acute migraine

Unmet medication need in neuropathic pain

Unmet medication need in neuropathic pain

Opioid tramadol can increase hospitalization risk for hypoglycemia

Opioid tramadol can increase hospitalization risk for hypoglycemia

Kids exposed to cooking or tobacco smoke more likely to suffer excessive pain after tonsillectomies

Kids exposed to cooking or tobacco smoke more likely to suffer excessive pain after tonsillectomies

Chemists able to trace narcotics substances, prescription drugs in Swedish wastewater

Chemists able to trace narcotics substances, prescription drugs in Swedish wastewater

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

Severe arthritis pain treatments: an interview with Professor Walsh, University of Nottingham and Professor Wood, UCL

Severe arthritis pain treatments: an interview with Professor Walsh, University of Nottingham and Professor Wood, UCL

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Drug release of tramadol hydrochloride increases from 1.9 to 7.5 hours by adding Novozymes Biopharma’s Hyasis®

Drug release of tramadol hydrochloride increases from 1.9 to 7.5 hours by adding Novozymes Biopharma’s Hyasis®

Eisai submits BELVIQ NDS with Health Canada

Eisai submits BELVIQ NDS with Health Canada

Teva to present abstracts on AZILECT at MDS meeting

Teva to present abstracts on AZILECT at MDS meeting

New challenges to military medicine

New challenges to military medicine

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Growth in opioid use prompts safety concerns

Growth in opioid use prompts safety concerns

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI